These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28974845)

  • 1. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
    Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
    Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
    Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
    Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
    McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.
    Vang R; Gupta M; Wu LS; Yemelyanova AV; Kurman RJ; Murphy KM; Descipio C; Ronnett BM
    Am J Surg Pathol; 2012 Mar; 36(3):443-53. PubMed ID: 22245958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review.
    Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K
    Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P57
    Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
    Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.
    Gupta M; Vang R; Yemelyanova AV; Kurman RJ; Li FR; Maambo EC; Murphy KM; DeScipio C; Thompson CB; Ronnett BM
    Am J Surg Pathol; 2012 Dec; 36(12):1747-60. PubMed ID: 22992698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of p57
    Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM
    Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.
    Gaillot-Durand L; Patrier S; Aziza J; Devisme L; Riera AC; Marcorelles P; Pelluard F; Gasser B; Mauduit C; Hajri T; Massardier J; Bolze PA; Golfier F; Devouassoux-Shisheboran M; Allias F
    Hum Pathol; 2020 Jul; 101():18-30. PubMed ID: 32387104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
    Yang SM; You JF; Zhang XW; Zheng J; Liao SL
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
    McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
    Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diandric triploid hydatidiform mole with loss of maternal chromosome 11.
    DeScipio C; Haley L; Beierl K; Pandit AP; Murphy KM; Ronnett BM
    Am J Surg Pathol; 2011 Oct; 35(10):1586-91. PubMed ID: 21881485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
    Xing D; Miller K; Beierl K; Ronnett BM
    Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of morphologic and immunohistochemical stain (p57
    Oranratanaphan S; Khongthip Y; Areeruk W; Triratanachat S; Tantbirojn P; Phupong V; Vongpaisarnsin K; Lertkhachonsuk R
    Taiwan J Obstet Gynecol; 2020 Jul; 59(4):570-574. PubMed ID: 32653131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
    Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole.
    Popiolek DA; Yee H; Mittal K; Chiriboga L; Prinz MK; Caragine TA; Budimlija ZM
    Hum Pathol; 2006 Nov; 37(11):1426-34. PubMed ID: 16949913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
    Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraploid partial hydatidiform mole: a case report and review of the literature.
    Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
    Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes.
    Zainal N; Kampan NC; Rose IM; Ghazali R; Shafiee MN; Yussoff NH; Tamil A; Jamil MA; Hussin NH
    Horm Mol Biol Clin Investig; 2021 May; 42(3):311-316. PubMed ID: 34018382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.